Augmentation of SSRI treatment

Augmentation of SSRI treatment

Opis bibliograficzny
1. autor:	Cowen, P
Format:	Journal article
Wydane:	2008

Podobne zapisy

SSRI treatment decreases prolactin and hyperthermic responses to mCPP.
od: Quested, D, i wsp.
Wydane: (1997)

Short-term SSRI treatment remediates amygdala hyperactivity in depressed patients
od: Godlewska, B, i wsp.
Wydane: (2011)

Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients.
od: Godlewska, B, i wsp.
Wydane: (2012)

Changes in plasma prolactin during SSRI treatment: evidence for a delayed increase in 5-HT neurotransmission.
od: Cowen, P, i wsp.
Wydane: (1997)

Neural response to implicit emotions as biomarkers of clinical response to SSRI treatment in depression
od: Godlewska, B, i wsp.
Wydane: (2017)

Early changes in emotional processing as a marker of clinical response to SSRI treatment in depression
od: Godlewska, B, i wsp.
Wydane: (2016)

'It's the way that you look at it'--a cognitive neuropsychological account of SSRI action in depression.
od: Harmer, C, i wsp.
Wydane: (2013)

'It's the way that you look at it'--a cognitive neuropsychological account of SSRI action in depression.
od: Harmer, C, i wsp.
Wydane: (2013)

Normalization of enhanced fear recognition by acute SSRI treatment in subjects with a previous history of depression.
od: Bhagwagar, Z, i wsp.
Wydane: (2004)

SHORT-TERM SSRI TREATMENT REMEDIATES AMYGDALA HYPERACTIVITY IN DEPRESSED PATIENTS: A PLACEBO-CONTROLLED STUDY
od: Godlewska, B, i wsp.
Wydane: (2011)

Does tryptophan supplementation induce similar changes in emotional processing to an SSRI?
od: Murphy, SE, i wsp.
Wydane: (2005)

SSRI-induced hyponatremia
od: Archana Javadekar, i wsp.
Wydane: (2014-01-01)

Post-SSRI sexual dysfunction and SSRI induced sexual dysfunction - literature review
od: Eliasz Panek, i wsp.
Wydane: (2023-04-01)

Differences between SSRI and SNRI in depression treatment
od: Mateusz Grego, i wsp.
Wydane: (2025-01-01)

Acute SSRI administration affects the processing of social cues in healthy volunteers.
od: Harmer, C, i wsp.
Wydane: (2003)

Olanzapine increases slow wave sleep and sleep continuity in SSRI-resistant depressed patients.
od: Sharpley, A, i wsp.
Wydane: (2005)

The knowns and unknowns of SSRI treatment in young people with depression and anxiety: efficacy, predictors, and mechanisms of action
od: Murphy, SE, i wsp.
Wydane: (2021)

Fronto-limbic effective connectivity as possible predictor of antidepressant response to SSRI administration
od: Vai, B, i wsp.
Wydane: (2016)

SSRI Facilitated Crack Dancing
od: Ravi Doobay, i wsp.
Wydane: (2017-01-01)

Using pharmacological fMRI to examine the effect of an SSRI on the neural circuitry underpinning threat processing
od: Murphy, S, i wsp.
Wydane: (2008)

Investigation of the SSRI augmentation properties of 5-HT(2) receptor antagonists using in vivo microdialysis.
od: Boothman, L, i wsp.
Wydane: (2006)

Decreased neural response to fear after a short-term SSRI treatment: a 3T functional magnetic resonance imaging study
od: Godlewska, B, i wsp.
Wydane: (2011)

Using pharmacological fMRI to examine the effect of an SSRI on the neural circuitry underpinning threat processing
od: Murphy, SE, i wsp.
Wydane: (2008)

SSRI administration reduces resting state functional connectivity in dorso-medial prefrontal cortex
od: McCabe, C, i wsp.
Wydane: (2011)

SSRI administration reduces resting state functional connectivity in dorso-medial prefrontal cortex.
od: McCabe, C, i wsp.
Wydane: (2011)

Placental glucocorticoid receptors are not affected by maternal depression or SSRI treatment
od: Åsa Edvinsson, i wsp.
Wydane: (2020-01-01)

Stimulant and SSRI Medication Trends in ADHD
od: J Gordon Millichap
Wydane: (2001-06-01)

THE SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI) AS TREATMENT OF DEPRESSION IN PATIENTS WITH EPILEPSY
od: Yu. V. Solomatin, i wsp.
Wydane: (2016-12-01)

Effects of SSRI treatment on GABA and glutamate levels in an associative relearning paradigm
od: B. Spurny, i wsp.
Wydane: (2021-05-01)

Ssri-treated psychiatric disorders prediction with AI
od: A. Mereu
Wydane: (2021-04-01)

Serotonin Syndrome Due to Overdose Intake of SSRI
od: Yavuz Orak, i wsp.
Wydane: (2015-08-01)

SSRI use in pregnancy: Evaluating the risks and benefits
od: Elsa du Toit, i wsp.
Wydane: (2015-05-01)

A Case of SSRI Induced Irreversible Parkinsonism
od: Siddharth Dixit, i wsp.
Wydane: (2015-02-01)

Profiling placental DNA methylation associated with maternal SSRI treatment during pregnancy
od: Amy M. Inkster, i wsp.
Wydane: (2022-12-01)

SSRI Treatment Response Prediction in Depression Based on Brain Activation by Emotional Stimuli
od: Antonia Preuss, i wsp.
Wydane: (2020-11-01)

Clinico-biochemical Study of the Safety and Tolerability of Selective Serotonin Reuptake Inhibitors (SSRI) with Special Reference to SSRI Induced Hyponatremia in Humans and Animals
od: Suhena Sarkar, i wsp.
Wydane: (2021-03-01)

Investigation of the behavioural and neurobiological effects of SSRI discontinuation in mice
od: Collins, HM
Wydane: (2023)

SSRI induced hypnic jerks: A case series
od: Rakesh Kumar, i wsp.
Wydane: (2023-07-01)

LONGTERM OFF-LABEL USE OF SSRI IN TREATMENT OF EARLY EJACULATION: TWO CASES REPORT
od: E. Becirovic, i wsp.
Wydane: (2023-03-01)

Low-Dose Quetiapine in the Treatment of SSRI-Induced Bruxism and Mandibular Dystonia: Case Series
od: Atefeh zandifar, i wsp.
Wydane: (2018-06-01)